tiprankstipranks
NewAmsterdam Pharma Company (NAMS)
NASDAQ:NAMS
US Market

NewAmsterdam Pharma Company (NAMS) Stock Investors

67 Followers
Based on 743,457 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold NAMS
On average, investors allocate 0.00% of their portfolios to NAMS
The average holding size of this company in investors' portfolios.

Investor Sentiment

Neutral
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 743,457 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding NAMS

1.2%
Last 7
Days
1.9%
Last 30
Days
Percentages indicate the change in the number of portfolios holding NAMS, out of 743,457 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

NAMS Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
0.01%
$23.05
Opened
0.34%
$22.03
Based on the activity of 14,068 investors who made their portfolios public
The table shows changes in NAMS in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

NAMS Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Merck & Company
3.93%
+0.06%
+3.11%
313.56B
Healthcare
Chipotle
5.35%
+11.53%
+35.22%
86.04B
Consumer Cyclical
PDD Holdings
4.93%
-0.15%
+5.39%
176.64B
Consumer Cyclical
Trade Desk
4.68%
-0.66%
+1.07%
47.77B
Technology
NextEra Energy
4.00%
-0.51%
-0.48%
145.48B
Utilities
Baidu
5.02%
+0.57%
+11.22%
31.69B
Communication Services
DraftKings
5.75%
-0.33%
-1.13%
33.50B
Consumer Cyclical
Fortinet
3.40%
-0.66%
-2.61%
46.04B
Technology
Delta Air Lines
5.37%
+0.14%
-0.08%
30.61B
Industrials
Applied Materials
4.72%
+0.03%
+4.17%
195.39B
Technology
Based on the activity of 743,457 active portfolios
Open your Smart Portfolio

NAMS Investor Analysis

NAMS investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
7.7%
of NAMS holders
are under 35
Average Segment Performance
Average P/E Ratio21.46
Beta7.39
Dividend Yield6.06%
NAMS investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
84.6%
of NAMS holders
are between 35–55
Average Segment Performance
Average P/E Ratio20.66
Beta13.51
Dividend Yield6.08%
NAMS investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
7.7%
of NAMS holders
are over 55
Average Segment Performance
Average P/E Ratio20.71
Beta4.77
Dividend Yield7.20%
Overview of age group and performance of NAMS stock investors
See who invests in NAMS according to age group and performance.

FAQ

How many retail Investors hold NAMS?
<0.1% of TipRanks' retail investors hold NAMS in their portfolios.
    What is NAMS Investor Sentiment?
    NAMS’s Investor Sentiment is Neutral.
      What percentage of retail investors changed their holding of NAMS in the last 7 days?
      ▼ 1.2% of TipRanks' retail investors changed their holding of NAMS in the last 7 days.
        What percentage of retail investors changed their holding of NAMS in the last 30 days?
        ▲ 1.9% of TipRanks' retail investors changed their holding of NAMS in the last 30 days.
          What is the average age of retail investors who hold NAMS?
          The average age of NAMS Holders is between 35–55.
            What other stocks have NAMS investors also bought?
            NAMS Investors also bought MRK, CMG, PDD, TTD, NEE, BIDU, DKNG, FTNT, DAL, AMAT.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AZNAstraZeneca
              BCRXBioCryst
              BSXBoston Scientific
              DVADaVita
              EWEdwards Lifesciences
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis